BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 26930182)

  • 1. Pediatric Thyroid Cancer: Postoperative Classifications and Response to Initial Therapy as Prognostic Factors.
    Lazar L; Lebenthal Y; Segal K; Steinmetz A; Strenov Y; Cohen M; Yaniv I; Yackobovitch-Gavan M; Phillip M
    J Clin Endocrinol Metab; 2016 May; 101(5):1970-9. PubMed ID: 26930182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of recurrence after total thyroidectomy in 1,611 patients with papillary thyroid carcinoma: postoperative stimulated serum thyroglobulin and ATA initial and dynamic risk assessment.
    Ywata de Carvalho A; Kohler HF; Ywata de Carvalho CCG; Vartanian JG; Kowalski LP
    Arch Endocrinol Metab; 2024 Apr; 68():e220506. PubMed ID: 38578436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of BRAF V600E Mutation and MicroRNA Expression with Central Lymph Node Metastases in Papillary Thyroid Cancer: A Prospective Study from Four Endocrine Surgery Centers.
    Han PA; Kim HS; Cho S; Fazeli R; Najafian A; Khawaja H; McAlexander M; Dy B; Sorensen M; Aronova A; Sebo TJ; Giordano TJ; Fahey TJ; Thompson GB; Gauger PG; Somervell H; Bishop JA; Eshleman JR; Schneider EB; Witwer KW; Umbricht CB; Zeiger MA
    Thyroid; 2016 Apr; 26(4):532-42. PubMed ID: 26950846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric Differentiated Thyroid Carcinoma in The Netherlands: A Nationwide Follow-Up Study.
    Klein Hesselink MS; Nies M; Bocca G; Brouwers AH; Burgerhof JG; van Dam EW; Havekes B; van den Heuvel-Eibrink MM; Corssmit EP; Kremer LC; Netea-Maier RT; van der Pal HJ; Peeters RP; Schmid KW; Smit JW; Williams GR; Plukker JT; Ronckers CM; van Santen HM; Tissing WJ; Links TP
    J Clin Endocrinol Metab; 2016 May; 101(5):2031-9. PubMed ID: 26963949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Genomic Alternative to Identify Medullary Thyroid Cancer Preoperatively in Thyroid Nodules with Indeterminate Cytology.
    Kloos RT; Monroe RJ; Traweek ST; Lanman RB; Kennedy GC
    Thyroid; 2016 Jun; 26(6):785-93. PubMed ID: 26992356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 2015 Survey of Clinical Practice Patterns in the Management of Thyroid Nodules.
    Burch HB; Burman KD; Cooper DS; Hennessey JV; Vietor NO
    J Clin Endocrinol Metab; 2016 Jul; 101(7):2853-62. PubMed ID: 27014951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inappropriate Suppression of Thyrotropin Concentrations in Young Patients with Thyroid Nodules Including Thyroid Cancer: The Fukushima Health Management Survey.
    Suzuki S; Nakamura I; Suzuki S; Ohkouchi C; Mizunuma H; Midorikawa S; Fukushima T; Ito Y; Shimura H; Ohira T; Matsuzuka T; Ohtsuru A; Abe M; Yamashita S; Suzuki S
    Thyroid; 2016 May; 26(5):717-25. PubMed ID: 26971545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid Stimulating Antibodies Are Highly Prevalent in Hashimoto's Thyroiditis and Associated Orbitopathy.
    Kahaly GJ; Diana T; Glang J; Kanitz M; Pitz S; König J
    J Clin Endocrinol Metab; 2016 May; 101(5):1998-2004. PubMed ID: 26964732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Etiology and Clinical Features of Non-CAH Gonadotropin-Independent Precocious Puberty: A Multicenter Study.
    Atay Z; Yesilkaya E; Erdeve SS; Turan S; Akin L; Eren E; Doger E; Aycan Z; Abali ZY; Akinci A; Siklar Z; Ozen S; Kara C; Tayfun M; Sari E; Tutunculer F; Karabulut GS; Karaguzel G; Cetinkaya S; Saglam H; Bideci A; Kurtoglu S; Guran T; Bereket A
    J Clin Endocrinol Metab; 2016 May; 101(5):1980-8. PubMed ID: 26964727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inter-Observer Variation in the Pathologic Identification of Minimal Extrathyroidal Extension in Papillary Thyroid Carcinoma.
    Su HK; Wenig BM; Haser GC; Rowe ME; Asa SL; Baloch Z; Du E; Faquin WC; Fellegara G; Giordano T; Ghossein R; LiVolsi VA; Lloyd R; Mete O; Ozbek U; Rosai J; Suster S; Thompson LD; Turk AT; Urken ML
    Thyroid; 2016 Apr; 26(4):512-7. PubMed ID: 26953223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nodal metastases in thyroid cancer: prognostic implications and management.
    Wang LY; Ganly I
    Future Oncol; 2016 Apr; 12(7):981-94. PubMed ID: 26948758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRAF and TERT promoter mutations in the aggressiveness of papillary thyroid carcinoma: a study of 653 patients.
    Jin L; Chen E; Dong S; Cai Y; Zhang X; Zhou Y; Zeng R; Yang F; Pan C; Liu Y; Wu W; Xing M; Zhang X; Wang O
    Oncotarget; 2016 Apr; 7(14):18346-55. PubMed ID: 26943032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid Cancer in the Pediatric Population.
    Paulson VA; Rudzinski ER; Hawkins DS
    Genes (Basel); 2019 Sep; 10(9):. PubMed ID: 31540418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic Risk Stratification in the Follow-Up of Children and Adolescents with Differentiated Thyroid Cancer.
    Zanella AB; Scheffel RS; Nava CF; Golbert L; Laurini de Souza Meyer E; Punales M; Gonçalves I; Dora JM; Maia AL
    Thyroid; 2018 Oct; 28(10):1285-1292. PubMed ID: 30129889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of differentiated thyroid cancer in children and young adults: risk stratification by ATA criteria and assessment of pre-ablation stimulated thyroglobulin as predictors of disease persistence.
    Karapanou O; Tzanela M; Rondogianni P; Dacou-Voutetakis C; Chiotis D; Vlassopoulou B; Vassiliadi D; Kanaka-Gantenbein C; Tsagarakis S
    Endocrine; 2020 Dec; 70(3):566-574. PubMed ID: 32533509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of dynamic risk stratification in pediatric patients with differentiated thyroid carcinoma.
    Kim K; Kim WW; Choi JB; Kim MJ; Lee CR; Lee J; Kang SW; Nam KH; Chung WY; Jeong JJ
    Ann Surg Treat Res; 2018 Oct; 95(4):222-229. PubMed ID: 30310805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Factors for Early and Long-Term Remission in Pediatric Differentiated Thyroid Carcinoma: The Role of Sex, Age, Clinical Presentation, and the Newly Proposed American Thyroid Association Risk Stratification System.
    Pires BP; Alves PA; Bordallo MA; Bulzico DA; Lopes FP; Farias T; Dias F; Lima RA; Santos Gisler IC; Coeli CM; Carvalhaes de Oliveira RV; Corbo R; Vaisman M; Vaisman F
    Thyroid; 2016 Oct; 26(10):1480-1487. PubMed ID: 27540892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does it work in childhood and adolescence? The predictive role of postoperative/preablative stimulated thyroglobulin levels in paediatric thyroid cancer. A systematic review of the literature.
    Piccardo A; Fiz F; Bottoni G; Foppiani L; Albano D; Bertagna F; Catrambone U; Mariani F; Sambucco B; Massollo M; Treglia G; Trimboli P
    Rev Endocr Metab Disord; 2024 Feb; 25(1):53-63. PubMed ID: 37743443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features of thyroid cancer in paediatric age. Experience of a tertiary centre in the 2000-2020 period.
    Tuli G; Munarin J; Matarazzo P; Marino A; Corrias A; Palestini N; Quaglino F; De Sanctis L
    Endocrine; 2023 Aug; 81(2):322-329. PubMed ID: 37071323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiated Thyroid Cancer in a Pediatric Population: Estimating the Risk of Recurrence and Evolution Over Time.
    Damásio I; Dias D; Pinheiro S; Esteves S; Leite V; Santos R
    Cureus; 2023 Jan; 15(1):e34313. PubMed ID: 36860222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.